Spots Global Cancer Trial Database for adult lymphocyte predominant hodgkin lymphoma
Every month we try and update this database with for adult lymphocyte predominant hodgkin lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment | NCT00881387 | Lymphoma | rituximab gemcitabine hyd... vinorelbine dit... | 18 Years - 120 Years | University of Miami | |
| A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT01460940 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular L... Adult Nodular S... Recurrent Adult... | panobinostat lenalidomide | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma | NCT01118026 | Lymphoma | ABVD BEACOPP radiation thera... | 18 Years - 60 Years | Alliance for Clinical Trials in Oncology | |
| Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma | NCT00132028 | Adult Favorable... Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular L... Adult Nodular S... Adult Unfavorab... Recurrent Adult... | vorinostat laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | NCT00337194 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Recurrent Adult... | monoclonal anti... placebo vinorelbine tar... pegylated lipos... gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma | NCT01476410 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Stage II Adult ... Stage III Adult... Stage IV Adult ... | brentuximab ved... doxorubicin hyd... vinblastine dacarbazine quality-of-life... DNA analysis RNA analysis fludeoxyglucose... positron emissi... laboratory biom... immunohistochem... polymorphism an... | 60 Years - | Northwestern University | |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | NCT00678327 | Lymphoma | bleomycin sulfa... filgrastim pegfilgrastim cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisolone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 100 Years | University College, London | |
| Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease | NCT00002561 | Hodgkin Lymphom... | bleomycin sulfa... dacarbazine doxorubicin hyd... vinblastine radiation thera... | 16 Years - | Canadian Cancer Trials Group | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | NCT00041210 | Lymphoma | bleomycin sulfa... ABVD regimen Stanford V regi... dacarbazine doxorubicin hyd... etoposide mechlorethamine... prednisone vinblastine sul... vincristine sul... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | NCT00002715 | Lymphoma | Bleomycin sulfa... Stanford V regi... Doxorubicin hyd... Etoposide Mechlorethamine... Prednisone Vinblastine Vincristine sul... | 18 Years - 60 Years | Stanford University | |
| Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT01535924 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular L... Adult Nodular S... Recurrent Adult... | gemcitabine hyd... bendamustine hy... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT01460940 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular L... Adult Nodular S... Recurrent Adult... | panobinostat lenalidomide | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00005584 | Lymphoma | bleomycin sulfa... ABVD regimen BEACOPP regimen epirubicin hydr... prednisone vinblastine sul... radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma | NCT00132028 | Adult Favorable... Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular L... Adult Nodular S... Adult Unfavorab... Recurrent Adult... | vorinostat laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | NCT00002461 | Lymphoma | filgrastim sargramostim carmustine cisplatin cyclophosphamid... etoposide autologous bone... in vitro-treate... peripheral bloo... radiation thera... | 15 Years - 65 Years | Montefiore Medical Center | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | NCT00002461 | Lymphoma | filgrastim sargramostim carmustine cisplatin cyclophosphamid... etoposide autologous bone... in vitro-treate... peripheral bloo... radiation thera... | 15 Years - 65 Years | Montefiore Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
